Prevention of Chemotherapy-induced Cardiotoxicity in High-risk Patients
NCT00292526
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
114
Enrollment
OTHER
Sponsor class
Conditions
Cardiotoxicity
Chemotherapeutic Toxicity
Interventions
DRUG:
Enalapril
Sponsor
European Institute of Oncology